Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
239.56(c) 239.25(c) 243.35(c) 245.41(c) 242.64(c) Last
1 187 302 1 501 366 1 239 225 1 115 415 1 131 258 Volume
-0.46% -0.13% +1.71% +0.85% -1.13% Change
More quotes
Financials (USD)
Sales 2021 19 455 M - -
Net income 2021 2 308 M - -
Net Debt 2021 13 630 M - -
P/E ratio 2021 30,3x
Yield 2021 1,53%
Sales 2022 19 282 M - -
Net income 2022 2 498 M - -
Net Debt 2022 11 711 M - -
P/E ratio 2022 26,4x
Yield 2022 1,59%
Capitalization 70 564 M 70 564 M -
EV / Sales 2021 4,33x
EV / Sales 2022 4,27x
Nbr of Employees 72 000
Free-Float 79,2%
More Financials
Company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a... 
More about the company
Ratings of Becton, Dickinson and Company
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about BECTON, DICKINSON AND COMPANY
06/11BECTON DICKINSON ANDá : USA Swimming Partners with BD to Provide COVID-19 Screen..
PR
06/08INOGENá : Appoints Becton Dickinson Executive Stanislav Glezer as Chief Medical ..
MT
06/08BECTON DICKINSON ANDá : Reaches Injection Device Milestone in Support of Global ..
MT
06/08BECTON DICKINSON ANDá : BD Hits 2 Billion Injection Device Milestone in Support ..
PR
06/08BECTON, DICKINSON AND COMPANY : Ex-dividend day for
FA
06/02INSIDER TRENDS : Selling By Insiders Lingers at Becton Dickinson
MT
06/02BECTON DICKINSON ANDá : BD Advances Leadership in Cybersecurity Preparedness, Tr..
PR
06/01Abbott cuts 2021 profit forecast on lower COVID-19 testing demand
RE
05/26BECTON DICKINSON ANDá : BD to Present at Upcoming Investor Conferences in June
PR
05/26BECTON DICKINSON ANDá : BD Leverages Artificial Intelligence To Transform Microb..
PR
05/25BECTON DICKINSON ANDá : Barclays Initiates Coverage on Becton, Dickinson and Com..
MT
05/25BECTON DICKINSON ANDá : BD Launches Industry First Ready-to-Use Iodine-Based Sur..
PR
05/21BECTON DICKINSON ANDá : Bionity- BD to Build New EUR165 Million Manufacturing Fa..
AQ
05/19BECTON DICKINSON ANDá : Dickinson - BD to Build New EUR165 Million Manufacturing..
AQ
05/18BECTON DICKINSON ANDá : BD to Build New $200 Million Manufacturing Plant in Spai..
MT
More news
News in other languages on BECTON, DICKINSON AND COMPANY
04/07DGAP-HV : Fresenius Medical Care AG & Co. KGaA: -4-
2020VIRUS : la fabrication de seringues tourne aussi à plein régime
2020Mettler Toledo prépare la transition à sa direction générale
2020OLIVIER FILLIOL : CEO Olivier Filliol wird durch Patrick Kaltenbach abgelöst
2020TESLAá : Elon Musk a passé quatre tests Covid-19, dont deux positifs !
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | BDX | US0758871091 | MarketScreener
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 279,80 $
Last Close Price 242,64 $
Spread / Highest target 23,6%
Spread / Average Target 15,3%
Spread / Lowest Target 7,15%
EPS Revisions
Managers and Directors
NameTitle
Thomas E. Polen Chairman, President & Chief Executive Officer
Christopher R. Reidy Chief Financial & Administrative Officer, EVP
William R. Sigmund Chief Medical Officer & Executive Vice President
Jerry Flasz Chief Information Officer & EVP-Global Services
Elizabeth McCombs Chief Technology Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
BECTON, DICKINSON AND COMPANY-3.03%70 564
ABBOTT LABORATORIES0.38%195 290
MEDTRONIC PLC5.67%166 534
ALIGN TECHNOLOGY, INC.14.44%48 395
HOYA CORPORATION-2.59%46 812
SARTORIUS STEDIM BIOTECH28.54%41 736